Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

BMPR2 variant may be related to pulmonary hypertension after lung irradiation

Masako Harada, Ai Yamada, Shun Nagasawa, Naoto Yamashita, Mariko Kinoshita, Koh-Ichiro Yoshiura, Hiroshi MoritakeUniversity of Miyazaki. Nagasaki University. Japan Pediatrics InternationalPediatr Int 2023; 65DOI: 10.1111/ped.15652 AbstractNo Abstract Available CategoryGenetic Factors Associated with Pulmonary Vascular DiseaseEnvironmental Factors Associated with Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease Fresh or Filed Publication: […]

BMPR2 variant may be related to pulmonary hypertension after lung irradiation Read More »

Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype

Elizabeth S. Doughty, Christian Norvik, Alice Levin, Jenna Bodmer, Karin Tran-Lundmark, Steven H. Abman, Csaba GalambosThe University of Colorado and Children’s Hospital Colorado. Lund University and Wallenberg Center for Molecular Medicine.United States and Sweden Pediatric and Developmental PathologyPediatr and Dev Pathol 2023; DOI: 10.1177/10935266231199933 AbstractTbx4 protein, expressed in mesenchyme of the developing lung, contributes to airway

Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype Read More »

Early Outcomes for In Situ Pericardial Roll Repair for Distant Anomalous Pulmonary Venous Return

Hani K. Najm, Munir Ahmad, Yezan Salam, Jared Klein, Saad M. Hasan, David Majdalany, Robert D. Stewart, Gosta Pettersson, Tara KaramlouCleveland Clinic Children’s Hospital and Cleveland Clinic. Alfaisal University.United States and Saudi Arabia Annals of Thoracic SurgeryAnn Thorac Surg 2021; 111: 169-175DOI: 10.1016/j.athoracsur.2020.03.063 AbstractBackground: Repair of anomalous pulmonary venous return (APVR) when veins are remote from the

Early Outcomes for In Situ Pericardial Roll Repair for Distant Anomalous Pulmonary Venous Return Read More »

Right partial anomalous pulmonary venous connection to the superior vena cava following the Warden procedure

Carine Pavy, Nathaly Gavira, Pierre Maminirina, Olivier BaronUniversity Hospital Nantes.France Journal of Cardiac SurgeryJ Card Surg 2018; 33: 565-569DOI: 10.1111/jocs.13782 AbstractBackground and aims: Surgical repair of right partial pulmonary anomalous connection to the superior vena cava (SVC) with the Warden procedure can be complicated by SVC obstruction, pulmonary veins obstruction, and sinus node dysfunction. We review our

Right partial anomalous pulmonary venous connection to the superior vena cava following the Warden procedure Read More »

Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease

J. M. Chinawa, I. Arodiwe, J. T. Onyia, A. T. ChinawaUniversity of Nigeria/University of Nigeria Teaching Hospital. Enugu State University College of Medicine. Nigeria West African Journal of MedicineWest Afr J Med 2023; 40: 973-981DOI Not Available AbstractBackground: Eisenmenger syndrome (ES) is a rare condition seen in children with congenital heart disease (CHD). It is characterized

Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease Read More »

Cardiopulmonary Morbidity in Adults Born With Congenital Diaphragmatic Hernia

Ulrike S. Kraemer, Lieke S. Kamphuis, Pierluigi Ciet, Lidewij Visser, Dick Tibboel, Beatrijs Bartelds, Suzan C. M. Cochius-den Otter, Ivode Blaauw, Joostvan Rosmalen, Saskia J. Gischler, J. Marco Schnater, HannekeI JsselstijnErasmus MC-Sophia Children’s Hospital. Radboudumc Amalia Children’s Hospital.Netherlands PediatricsPediatrics 2023; DOI: 10.1542/peds.2023-062341 AbstractObjectives: Studies concerning cardiopulmonary outcomes of adults born with congenital diaphragmatic hernia (CDH) are sparse.

Cardiopulmonary Morbidity in Adults Born With Congenital Diaphragmatic Hernia Read More »

Successful release of recurrent pulmonary venous obstruction after repair of totally anomalous pulmonary venous connection by transcatheter implantation of stents

Kenji Waki, Yoshio Arakaki, Kiyoshi BabaKurashiki Central HospitalJapan Cardiology in the YoungCardiol Young 2006; 16: 507-509DOI: 10.1017/S1047951106001028 AbstractWe report a 3-month-old female infant, in whom pulmonary venous obstruction occurred after repair of totally anomalous pulmonary venous connection, and which was successfully released by a transcatheter implantation of a stent using the transseptal approach. Close follow-up is

Successful release of recurrent pulmonary venous obstruction after repair of totally anomalous pulmonary venous connection by transcatheter implantation of stents Read More »

Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta-analysis

Shang Wang, Yi Yan, Jian Zhang, Ping Yuan, Ci-Jun Luo, Hong-Ling Qiu, Hui-Ting Li, Lan Wang, Tian-Lan Li, Rong Jianghanghai Pulmonary Hospital, School of Medicine, Tongji University. Shanghai Children’s Medical Center, National Children’s Medical Center, Shanghai Jiaotong University School of Medicine. The Second Affiliated Hospital of Chengdu Medical College. The Affiliated Hospital of Qingdao University.China

Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta-analysis Read More »

Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis

Hui Zhao, Lan Wang, Yi Yan, Qin-Hua Zhao, Jing He, Rong Jiang, Ci-Jun Luo, Hong-Ling Qiu, Yu-Qing Miao, Su-Gang Gong, Ping Yuan, Wen-Hui WuShanghai Pulmonary Hospital and Tongji University. University of Shanghai for Science and Technology. Shanghai Children’s Medical Center and Shanghai Jiao Tong University.China Frontiers in ImmunologyFront Immunol 2023; DOI: 10.3389/fimmu.2023.1197752 AbstractPulmonary fibrosis (PF) and

Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis Read More »

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan

Emi Matsugi, Shigeki Takashima, Shuhei Doteguchi, Tomomi Kobayashi, Motohiro OkayasuMallinckrodt Pharmaceuticals. Japan General Thoracic and Cardiovascular SurgeryGen Thorac Cardiovasc Surg 2023; DOI: 10.1007/s11748-023-01971-2 AbstractObjective: To evaluate the real-world safety and effectiveness of inhaled nitric oxide (INOflo® for Inhalation 800 ppm) for perioperative pulmonary hypertension associated with cardiac surgery in Japan.Methods: This was a prospective, non-interventional, all-case, post-marketing study of

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan Read More »

Scroll to Top